EPO Patents = 1

Forward Citations = 61

Loading Chart...

3 inventors (with patents filed for the assignee):

Francis Lee (13 out of 13 patents)

Jonathan D Steckbeck (13 out of 13 patents)

Hannes Holste (13 out of 13 patents)

13 patents: Sort by Forward Citations

1. 12614613 - Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates (2026-04-28),

2. 12462902 - Artificial intelligence engine architecture for generating candidate drugs (2025-11-04),

3. 12087404 - Generating anti-infective design spaces for selecting drug candidates (2024-09-10),

4. 12006541 - Methods and apparatuses for generating peptides by synthesizing a portion of a design space to identify peptides having non-canonical amino acids (2024-06-11),

5. 11967400 - Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates (2024-04-23),

6. 11848076 - Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates (2023-12-19),

7. 11587643 - Methods and apparatuses for a unified artificial intelligence platform to synthesize diverse sets of peptides and peptidomimetics (2023-02-21),

8. 11512345 - Methods and apparatuses for generating peptides by synthesizing a portion of a design space to identify peptides having non-canonical amino acids (2022-11-29),

9. 11462304 - Artificial intelligence engine architecture for generating candidate drugs (2022-10-04),

10. 11436246 - Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates (2022-09-06),

11. 11424008 - Generating anti-infective design spaces for selecting drug candidates (2022-08-23),

12. 11403316 - Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates (2022-08-02),

13. 11049590 - Artificial intelligence engine architecture for generating candidate drugs (2021-06-29),

Company Overview

Peptilogics, Inc. is a biotechnology company based in Pittsburgh, PA, specializing in the development of peptide-based therapeutics. The organization focuses on leveraging its proprietary peptide engineering platform to create innovative solutions for various medical challenges, particularly in the fields of infectious diseases and cancer. By harnessing the unique properties of peptides, Peptilogics aims to advance treatment options and improve patient outcomes through targeted therapies and novel drug candidates.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#152 in Pittsburgh, PA

#854 in Pennsylvania

#23,854 in US

#45,081 in the World

Pittsburgh, PA, United States of America

Peptilogics, Inc.

Forward Citations = 61

3 inventors:

Francis Lee (13 out of 13 patents)

Jonathan D Steckbeck (13 out of 13 patents)

Hannes Holste (13 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Peptilogics, Inc.. Retrieved from https://idiyas.com/company/peptilogics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]